Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 575 of 2051 entries
View as:

Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)

Phase: N/A Priority: Normal
NCT ID: NCT03379506 Org: User:
Start: 01/25/18 End: 07/23/20 Due: 07/23/21

GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Phase: N/A Priority: Normal
NCT ID: NCT01245764 Org: User:
Start: 03/21/11 End: 04/15/13 Due: 04/15/14

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

Phase: N/A Priority: Normal
NCT ID: NCT00764946 Org: User:
Start: 10/31/08 End: 02/28/11 Due: 02/28/12

Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00037661 Org: User:
Start: 04/30/02 End: 03/31/03 Due: 03/31/04

Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)

Phase: N/A Priority: Normal
NCT ID: NCT02702401 Org: User:
Start: 05/26/16 End: 09/22/21 Due: 09/22/22

A Study of MK0359 in Patients With Chronic Asthma (0359-013)

Phase: N/A Priority: Normal
NCT ID: NCT00482898 Org: User:
Start: 09/30/02 End: 04/30/03 Due: 04/30/04

A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)

Phase: N/A Priority: Normal
NCT ID: NCT00943722 Org: User:
Start: 08/27/09 End: 04/22/21 Due: 04/22/22

Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)

Phase: N/A Priority: Normal
NCT ID: NCT03740178 Org: User:
Start: 09/27/19 End: 02/28/20 Due: 02/28/21

Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01209741 Org: User:
Start: 10/31/07 End: 11/30/07 Due: 11/30/08

A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)

Phase: N/A Priority: Normal
NCT ID: NCT07025551 Org: User:
Start: 08/11/25 End: 02/25/26 Due: 02/25/27

A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

Phase: N/A Priority: Normal
NCT ID: NCT00945321 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Phase: N/A Priority: Normal
NCT ID: NCT00931606 Org: User:
Start: 06/01/09 End: 11/18/10 Due: 11/18/11

A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)

Phase: N/A Priority: Normal
NCT ID: NCT01313858 Org: User:
Start: 04/30/10 End: 09/30/15 Due: 09/30/16

Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003)

Phase: N/A Priority: Normal
NCT ID: NCT03840174 Org: User:
Start: 03/08/19 End: 11/07/19 Due: 11/07/20

Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

Phase: N/A Priority: Normal
NCT ID: NCT00387036 Org: User:
Start: 12/31/06 End: 07/31/09 Due: 07/31/10

MK0524B Bioequivalence Study (0524B-070)

Phase: N/A Priority: Normal
NCT ID: NCT00943124 Org: User:
Start: 07/31/07 End: 08/31/07 Due: 08/31/08

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)

Phase: N/A Priority: Normal
NCT ID: NCT02115321 Org: User:
Start: 05/09/14 End: 06/16/15 Due: 06/16/16

PegIntron Injection Surveillance Plan (Study P04123)

Phase: N/A Priority: Normal
NCT ID: NCT00723931 Org: User:
Start: 06/30/06 End: 11/30/09 Due: 11/30/10

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)

Phase: N/A Priority: Normal
NCT ID: NCT04016714 Org: User:
Start: 08/28/19 End: 10/29/21 Due: 10/29/22

A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)

Phase: N/A Priority: Normal
NCT ID: NCT01580228 Org: User:
Start: 08/31/12 End: 12/31/14 Due: 12/31/15

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Phase: N/A Priority: Normal
NCT ID: NCT06074588 Org: User:
Start: 11/12/23 End: 03/11/30 Due: 03/11/31

Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)

Phase: N/A Priority: Normal
NCT ID: NCT00289913 Org: User:
Start: 04/30/06 End: 06/30/10 Due: 06/30/11

Antihypertensive Response to Losartan and Genetic Polymorphisms

Phase: N/A Priority: Normal
NCT ID: NCT00617877 Org: User:
Start: 03/31/05 End: 06/30/09 Due: 06/30/10

Study to Treat Uveitis Associated Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00114062 Org: User:
Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Phase: N/A Priority: Normal
NCT ID: NCT00365443 Org: User:
Start: 10/31/06 End: - Due: -